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Motoneurons and oligodendrocytes in the embryonic spinal cord are produced from a restricted domain of the ventral ventricular zone, termed
the pMN domain. The pMN domain is the site of expression of two basic helix–loop–helix transcription factors, Olig1 and Olig2, which are
essential for motoneuron and oligodendrocyte development. Previous lineage-tracing experiments using Olig1-Cre and Olig2-GFP mice
suggested that motoneurons and oligodendrocytes, but not astrocytes, are produced from the pMN domain. However, important questions remain,
including the fate of neuroepithelial cells in the pMN domain, and specifically whether motoneurons and oligodendrocytes are the only types of
cells produced in the pMN domain. We performed lineage-tracing experiments using a tamoxifen-inducible Cre-recombinase inserted into the
Olig2 locus. We demonstrated that motoneurons and oligodendrocyte progenitors are derived from the Olig2+ progenitors in the pMN domain, and
also found that a subset of astrocytes at the ventral surface of the spinal cord and ependymal cells at the ventricular surface are also produced from
the pMN domain. These findings demonstrate that motoneurons and oligodendrocytes are not the only cell types originating from this domain.
© 2006 Elsevier Inc. All rights reserved.Keywords: Olig2; CreER; Recombination; Lineage tracing; Radial glia; Astrocyte; Glia limitans; Motoneuron; Oligodendrocyte; Ependymal cellIntroduction
Transcription factors are known to regulate cell type-specific
differentiation during formation of the central nervous system
(CNS). For example, in early developing spinal cord,
expression of basic helix–loop–helix (bHLH) and homeobox
transcription factors demarcates and yields distinct dorsoventral
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doi:10.1016/j.ydbio.2006.02.029become various neuronal or glial subtypes (Briscoe et al., 2000;
Jessell, 2000; Schuurmans and Guillemot, 2002). Motoneurons
and oligodendrocyte progenitors (OLPs) are produced sequen-
tially from a common domain of the ventral ventricular zone,
termed the pMN domain in the developing spinal cord
(Richardson et al., 2000). Olig1 and Olig2 are bHLH
transcriptional factors specifically expressed in the pMN
domain (Lu et al., 2000; Takebayashi et al., 2000; Zhou et al.,
2000). Gain-of-function (Lu et al., 2000; Mizuguchi et al.,
2001; Novitch et al., 2001; Zhou et al., 2000, 2001) and loss-of-
function (Lu et al., 2002; Park et al., 2002; Takebayashi et al.,
2002; Zhou and Anderson, 2002) studies have established that
Olig2 is essential for motoneuron and oligodendrocyte
development during early embryogenesis, and Olig1 has been
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(Lu et al., 2002; Xin et al., 2005).
Previous lineage-tracing analyses of Olig-expressing pro-
genitors using Olig1-Cre ROSA26R and Olig2-GFP mice have
suggested that Olig1- and Olig2-expressing cells generate only
motoneurons and oligodendrocytes and do not produce astro-
cytes (Lu et al., 2002; Zhou and Anderson, 2002). These results
suggest the hypothesis that oligodendrocytes and motoneurons
share common precursors, separate from astrocytes, and that
there are no tripotential (neuron/astrocyte/oligodendrocyte)
progenitors in the developing spinal cord (Lu et al., 2002;
Zhou and Anderson, 2002; reviewed by Rowitch et al., 2002).
However, in Olig2-GFP mice (Zhou and Anderson, 2002), only
short-term lineage analysis can be carried out, and it is difficult
to track Olig2 lineage cells after cessation of Olig2 gene
expression, since GFP-expression largely mimics Olig2-expres-
sion. Since Olig1 expression in early spinal cord is biphasic and
weaker than that of Olig2 (Lu et al., 2000; Mizuguchi et al.,
2001), findings for Olig1-Cre Rosa26R mice (Lu et al., 2002)
may apply to only a fraction of Olig2 lineage cells in early
development. In addition, Cre recombinase is active in all
Olig1+ cells including migrating OLPs in parenchyma, not only
those derived from pMN domain, but also those derived from
dorsal domains at later stages (Cai et al., 2005; Fogarty et al.,
2005; Vallstedt et al., 2005). To overcome these problems and to
label progenitors exclusively in the pMN domain within a
limited time window, we employed tamoxifen (TM)-inducible
Cre recombinase, CreER™, for lineage-tracing experiments.
Using mice with CreER™ knocked-in at the Olig2 locus and
loxP-flanked (floxed) reporter mice, we examined whether
motoneurons and oligodendrocytes are the only derivatives of
Olig2+ cells and whether astrocytes or other types of cells are
also generated from Olig2+ cells. We first demonstrated that
motoneurons and OLPs are derived from Olig2+ progenitors in
the pMN domain. We also found other labeled cell types:
astrocytes at the ventral pial surface of the spinal cord and
ependymal cells at the ventricular surface. Our findings
demonstrated that not only motoneurons and OLPs, but also a
subset of astrocytes and ependymal cells, are produced from the
pMN domain after down-regulation of Olig2 expression. In
addition, we found that there are Olig2+ radial glial cells in the
pMN domain at both neurogenic and gliogenic stages.
Materials and methods
Mice
Olig2KICreER mice, CAG-CAT-Z, and Z/EG mice have been previously
described (Novak et al., 2000; Sakai and Miyazaki, 1997; Takebayashi et al.,
2002). Heterozygous Olig2KICreER/WT mice are normal and histologically
indistinguishable from wild-type mice. Olig2KICreER/WT CAG-CAT-Z or
Olig2KICreER/WT Z/EG double-heterozygote males were crossed with wild-type
C57BL/6J (Japan SLC Inc., Shizuoka, Japan) females to obtain double-
heterozygote embryos. Midday of the day on which a vaginal plugs was
observed was considered 0.5 days postcoitum (dpc). All animal procedures were
performed in accordance with the Policies on the Use of Animals and Humans in
Neuroscience Research, revised and approved by the Society for Neuroscience
in 1995, guidelines described by the National Institutes of Health Guide for Care
and Use of Laboratory Animals, and the local Animal Care and Use Committee.Genotyping
DNA samples were prepared from tails for normal genotyping, or the caudal
part of embryos including the spinal cord for detection of recombined CAG-
CAT-Z allele. Tissues were incubated at 50°C overnight with gentle agitation in a
dissolving solution (50 mM KCl, 10 mM Tris–HCl [pH 8.3], 0.1 mg/ml gelatin,
0.45% NP-40, and 0.45% Tween 20 containing 200 μg/ml proteinase K). This
crude genomic DNA solution was directly used as template for polymerase
chain reaction (PCR) genotyping.Olig2KICreER/WTmice were genotyped by PCR
as described (Takebayashi et al., 2002). For PCR detection of the CAG-CAT-Z
allele, the lacZ primers ZA4 (5′-CGT TGC ACC ACA GAT GAA ACG C-3′)
and ZS4 (5′-CTC AAA CTG GCA GAT GCA CGG T-3′) were used. This pair
of primers amplifies a 206 bp fragment from the CAG-CAT-Z allele. For
detection of Cre-recombined CAG-CAT-Z allele, CA1 primer (5′-CTG CTA
ACC ATG TTC ATG CC-3′) for the CAG promoter and L3 primer (5′-GGC
CTC TTC GCT ATT ACG-3′) for the lacZ gene were used to amplify 580 bp
fragments from the recombined CAG-CAT-Z allele (Sakai and Miyazaki, 1997).
For detection of the Z/EG allele, EGFP1 primer (5′-GAC GTA AAC GGC CAC
AAG TT-3′) and EGFP2 primer (5′-GAA CTC CAG CAG GAC CAT GT-3′)
for the EGFP gene were used to amplify 609 bp fragments. PCR was performed
at 95°C for 9 min, followed by 95°C for 20 s, 56°C (for detection of CAG-CAT-Z
allele), 55°C (for detection of recombined CAG-CAT-Z allele), or 60°C (for
detection of Z/EG allele) for 30 s, and 72°C for 30 s; PCR was run for 37 cycles
(for CAG-CAT-Z) or 27 cycles (for Z/EG) on a thermal cycler (GeneAmp PCR
Systems 9700, Perkin-Elmer, Wellesley, MA) using AmpliTaq Gold (Applied
Biosystems, Foster City, CA).
Tamoxifen treatment
The CreER™ gene was constructed in accordance with a previous report
(Danielian et al., 1998). We fused Cre recombinase and mutated mouse estrogen
receptor α isoform (ER) gene, which has a FLAG tag at the C terminus
(Takebayashi et al., 2002). For lineage analysis of Olig2+ cells, it is important
that these cells be labeled during a narrow, defined time window. Since the half-
life of 4-hydroxytamoxifen (4-OHT) is relatively short (6 h, compared with 12 h
for tamoxifen (TM)) (Robinson et al., 1991), we used 4-OHT (H-6278, Sigma,
St. Louis, MO) as a ligand to activate CreER™, dissolving it in a DMSO–
ethanol–sesame oil (4:6:90) mixture at a concentration of 10 mg/ml. Pregnant
mice were injected intraperitoneally at E9.5, E10.5, E12.5, E14.5, or E15.5 with
1.5 mg of 4-OHT. The injections were performed between 8 a.m. and noon.
Embryos were analyzed at E10.5, E11.5, E12.5, E14.5, and E18.5. A single
3.0 mg injection of 4-OHT led to death of embryos.
Histology
All analyses in this study were performed on the spinal cord at thoracic
levels. The images were collected with an Olympus microscope (Olympus
BX51; Olympus, Japan) and digital camera system (Olympus DP70; Olympus),
or with confocal microscopy (Zeiss LSM-510, Nussloch, Germany).
For in situ hybridization (ISH) on cryosections, we used a modified version
of methods previously described (Ding et al., 2006). After perfusion-fixation,
tissues were fixed with 4% PFA, cryoprotected by 10% and 20% sucrose in
phosphate-buffered saline (PBS), embedded in OCT compound (Sakura
Finetechnical Co. Ltd., Tokyo, Japan), frozen, and sectioned at 18 μm thickness.
After ISH staining, the sections were counterstained using nuclear fast red. The
following plasmids were used for generation of probes: mouse Olig1, Olig2
(Takebayashi et al., 2000), CreER™ (Takebayashi et al., 2002), mouse
Neurogenin2 (Ngn2) (obtained as an EST clone from Open Biosystems,
Huntsville, AL; Genbank accession number BC055743), and rat Islet2 (Isl2)
(provided by Dr. Yasuto Tanabe, Mitsubishi Kagaku Institute of Life Sciences,
Tokyo, Japan). Digoxigenin-labeled single-stranded riboprobes were prepared
by transcription of linearized plasmids using T7, T3, or Sp6 RNA polymerase
and the DIG RNA labeling kit (Roche, Indianapolis, IN).
Immunohistochemistry was performed as previously described (Takebaya-
shi et al., 2002) using the following primary antibodies: rabbit polyclonal anti-
GFP antibody (1:3000; Molecular Probes, Eugene, OR), rabbit polyclonal anti-
Cre antibody (1:3000; Novagen, San Diego, CA), rat monoclonal anti-GFP
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anti-Olig2 antibody (1:100; IBL Co., Ltd., Japan), rabbit polyclonal anti-
GLAST antibody (1:1000; Coval Ab, France), mouse monoclonal RC2 (1:10;
a gift from Dr. Miyuki Yamamoto, University of Tsukuba, Ibaraki, Japan
(Misson et al., 1988)), mouse monoclonal anti-neurofilament (1:5; 2H3
hybridoma supernatant, Developmental Studies Hybridoma Bank (DSHB)),
and mouse monoclonal anti-HB9 antibody (1:25; 81.5C10 hybridoma
supernatant, DSHB (Tanabe et al., 1998)). For fluorescence immunostaining,
appropriate Alexa 488-, 568-, and 594-conjugated antibodies (1:1000;
Molecular Probes) were applied and nuclei were counterstained with Hoechst
33342 (1 μg/ml; Sigma). For diaminobenzidine (DAB) staining, we used a
Histofine Simple Stain MAX-PO kit (Nichirei Co., Tokyo, Japan) and
followed the manufacturer's protocol. The rodent MNR2 homolog has not
been identified, and the monoclonal antibody to MNR2 reacts with both
MNR2 and HB9 in chicks. Since the pattern of staining with the anti-chick
MNR2 is similar to that previously reported with HB9 in mouse tissue (Arber
et al., 1999; Tanabe et al., 1998), we used the anti-MNR2 antibody as the anti-
HB9 antibody in this study.
X-gal staining was performed as previously described (Leone et al., 2003;
Yamaguchi et al., 2005) using 5-bromo-4-chloro-3-indolyl-β-D-galactoside (X-
gal) (Nacalai Tesque) with minor modifications. For X-gal staining on sections,
embryos were fixed with 2% paraformaldehyde (PFA) for 1 h at room
temperature, then treated with 20% sucrose in PBS overnight at room
temperature, embedded in OCT compound, frozen, and then sectioned at
18 μm thickness. Sections were washed three times for 5 min in PBS, and
incubated 24 h with X-gal staining solution (5 mM K4[Fe(CN)6], 5 mM K3[Fe
(CN)6], 20 mM Tris–HCl (pH 7.3), 2 mM MgCl2, 0.2% NP40, 0.1% sodium
deoxycholate, and 0.1% X-gal in PBS) at room temperature. After incubation,
sections were washed once for 5 min in PBS and counterstained using nuclear
fast red. CAG-CAT-Z single transgenic mice or untreated double-heterozygote
mice were used as negative controls.
For double-staining including X-gal staining and immunostaining on
sections, we first performed X-gal staining, pre-blocked for 30 min, and
performed incubation overnight at room temperature with appropriate primary
antibodies: rat monoclonal anti-PDGFRα antibody (1:500; APA5; BD
Biosciences Pharmingen, San Diego, CA), mouse monoclonal anti-islet1
antibody (1:100; 39.4D5 hybridoma supernatant, DSHB; (Ericson et al.,
1992)), rabbit polyclonal anti-GFAP antibody (1:1000; DAKO Cytomation,
Glostrup, Denmark), mouse monoclonal anti-S100β antibody (1:1000; SH-B1;
Sigma), and mouse monoclonal anti-NeuN antibody (1:500; MAB377;
Chemicon, Temecula, CA). Antibody staining was developed with diamino-
benzidine (DAB) using a Histofine Simple Stain MAX-PO kit (Nichirei Co.)
following the manufacturer's protocol.
For whole-mount X-gal staining, embryos were fixed in 1% formaldehyde,
0.2% glutaraldehyde, 2 mM MgCl2, 5 mM EGTA, 0.2% NP40, and 0.1% Na-
deoxycholate in PBS, then washed three times for 5 min in 0.2% NP40 and 0.1%
Na-deoxycholate in PBS, and subsequently stained for 48 to 72 h in the X-gal
staining solution at room temperature as described. After staining, embryos were
washed twice for 20 min in 0.2% NP40 and 0.1% Na-deoxycholate in PBS and
then post-fixed in 4% PFA and 0.2% glutaraldehyde at 4°C overnight. After
being post-fixed, tissues were kept in PBS-EDTA. For double-staining with ISH
and immunostaining on sections, ISH was first carried out, followed by
immunostaining with DAB.
Electron microscopy
Electron microscopic analyses of X-gal-labeled cells were carried out as
previously described (Masahira et al., 2005). Briefly, E18.5 embryos were
transcardially perfused with 0.9% saline followed by 10 ml of 2% PFA and 2.5%
glutaraldehyde in phosphate buffer (PB; 0.1 M, pH 7.4), then post-fixed in 2.5%
glutaraldehyde for 6 h at 4°C, washed 5 times for 5 min in PB containing 2 mM
MgCl2, and then overnight in PB containing 2 mM MgCl2. Transverse 70 μm
sections at thoracic levels were cut on a tissue slicer (Microslicer DTK-3000,
Dosaka, Kyoto, Japan), and stained overnight in X-gal solution as described at
4°C. Then, sections were washed three times for 5 min with PB, postfixed in 1%
osmium tetroxide for an hour at 4°C, and dehydrated in ethanol. For preservation
of X-gal reactants, sections were treated with hydroxypropyl methacrylate and
embedded in Epon. Ultrathin sections were cut, then stained with 2% uranylacetate aqueous solution followed by lead citrate, and examined with an electron
microscope (JEM-1010; JEOL, Tokyo, Japan). Ultrathin sections of wild-type
mouse spinal cord were prepared as a control for standard morphological
observation, with omission of the X-gal staining procedure.
Acutely dissociated cell culture and immunocytochemistry
The spinal cord was dissected out from E11.5 mouse embryos and
dissociated into a single-cell suspension by gently triturating with fire-
polished glass Pasteur pipette in Dulbecco's modified Eagle's medium
(DMEM; Sigma). The cells were centrifuged and re-suspended in Neurobasal
Medium (Invitrogen, San Diego, CA) supplemented with B27 (Invitrogen),
25 μM glutamic acid and 0.5 mM L-glutamine. They were plated in BD
FALCON CultureSlides (BD Biosciences), pre-coated with polyethylenimine
(PEI; Sigma) and laminin (10 μg/ml; BD Biosciences), and then incubated at
37°C under 5% CO2 for 1.5 h. After incubation, cultures were fixed with 4%
PFA at room temperature for 15 min and washed twice with PBS. Double
labeling with Olig2 and RC2 was performed as described above. Nuclei were
stained using Hoechst 33342.Results
Strategy for tamoxifen-inducible recombination
We used Olig2KICreER/WT mice, which express CreER™ re-
combinase under the control of endogenous Olig2 transcription
regulatory elements (Takebayashi et al., 2002).Two reportermice
were used: CAG-CAT-Z mice, which express the lacZ reporter
gene after excision of a floxed CAT gene by Cre-mediated re-
combination (Sakai andMiyazaki, 1997), and Z/EGmice, which
express the EGFP reporter gene after excision of a floxed lacZ
gene (Novak et al., 2000). By intercrossing these mice, we ob-
tained double-heterozygote embryos, Olig2KICreER/WT CAT-Z or
Olig2KICreER/WT Z/EG, which have both the Olig2KICreER allele
and the reporter allele, CAG-CAT-Z or Z/EG, heterozygously. In
these double-heterozygote mice, CreER™ protein is produced
in Olig2+ cells, but is functionally inactive in the absence of
tamoxifen. When tamoxifen binds to the ligand-binding
domain of the mutated estrogen receptor (ER™), CreER™
protein excises the floxed gene, resulting in reporter gene
expression. Since this DNA rearrangement is a heritable
event, reporter gene expression persists not only in Olig2+
cells, but also in their progeny, enabling detection of these
cells by X-gal staining or immunostaining for anti-GFP
antibody at later stages. Of note, recombination appears to
begin 6 h later and peak tagging occurs between 12 and 24 h
postinjection (Zervas et al., 2004).
Verification of faithful CreER™ expression in Olig2+ cells
To verify faithful CreER™ expression in Olig2+ cells, in
situ hybridization (ISH) was performed on serial sections at
E9.5 and E10.5 (Figs. 1A–F). We confirmed that CreER™
was faithfully expressed in the pMN domain (Figs. 1B, E). In
contrast, CreER™ expression was not detected in Olig2WT/WT
embryo (Fig. 1C). Notably, Isl2+ motoneurons in the ventral
horn, which were considered to be derived from the Olig2-
expressing pMN domain, no longer expressed Olig2 and
CreER™ (Fig. 1F).
Fig. 1. Faithful expression of CreER™ in Olig2+ cells. (A–F) In situ hybridization (ISH) with antisense RNA probes for Olig2 (A, D), CreER™ (B, C, E), and
motoneuron marker, Islet2 (F) was performed on spinal cord sections of E9.5 Olig2KICreER/WT (A, B), E9.5 Olig2WT/WT (C), and E10.5Olig2KICreER/WT embryos (D–F).
(A, D) Expression of Olig2 was restricted to the ventral domain of the spinal cord corresponding to the pMN domain at E9.5 and E10.5. (B, E) Expression of CreER™
driven by endogenous Olig2 transcription regulatory elements was identical to that of endogenousOlig2 (A,D respectively). (C) No CreER™ expression was detected
in Olig2WT/WT embryo. (F) Expression of the motoneuron marker Islet2 (Isl2) was detected in the ventral horn. (G, H) Induction of nuclear translocation of CreER™
protein by tamoxifen. Sections of Olig2KICreER/WT embryos 24 h after 4-OHT treatment at E9.5 (H) or without 4-OHT treatment (G) were immunostained with anti-Cre
antibody. Note that CreER™ is confined to the cytoplasm of cells in the pMN domain of a control animal (G), while CreER™ translocates into the nucleus of cells in
the pMN domain of 4-OHT-treated animals (H). Scale bars: A, B, C, 200 μm; D, E, F, 100 μm; G, 25 μm.
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protein, we compared intracellular localization of the protein
in 4-hydroxytamoxifen (4-OHT)-treated and -untreated
Olig2KICreER/WT embryos. Immunohistochemical examination
with anti-Cre antibody showed that translocation of
CreER™ protein from cytoplasm to nucleus occurred after
4-OHT treatment (Figs. 1G, H), suggesting that CreER™
translocates from cytoplasm into the nucleus after binding of
tamoxifen, and then catalyzes recombination.
Specific recombination in the Olig2KICreER/WT CAT-Z
double-heterozygote embryos
To test the specificity of tamoxifen-dependent Cre recombi-
nase activity in Olig2KICreER/WT CAT-Z double-heterozygote
embryos, we performed whole-mount X-gal staining. Pregnant
females were injected with 1.5 mg of 4-OHT at E10.5, and
Olig2KICreER/WT CAT-Z embryos were examined using whole-
mount X-gal staining 48 h after injection (Fig. 2A). In the
Olig2KICreER/WT CAT-Z embryos treated with 4-OHT, lacZ+
cells were observed in the pMN domain and in the ventral hornwhere motoneurons settle after migrating from the pMN domain
(Figs. 2B–D). Importantly, since Olig2 expression was
restricted to the pMN domain, and ventral horn motoneurons,
which migrated out from the Olig2+ pMN domain, no longer
expressed Olig2 from E10.5 (Fig. 1D) onwards, it was directly
demonstrated that Olig2− motoneurons in the ventral horn are
derived from Olig2+ progenitors in the pMN domain. These
findings also confirmed that lacZ expression was inherited from
motoneuron precursors in the pMN domain, which transiently
expressed Olig2 at E10.5. As a control experiment, pregnant
females were injected with the same volume of carrier alone at
E10.5, and Olig2KICreER/WT CAT-Z embryos were examined as
described above. In these control Olig2KICreER/WT CAT-Z
embryos, no lacZ+ cells were observed (Figs. 2E, F). This
control experiment was also performed using spinal cord of
E14.5 or E18.5 Olig2KICreER/WT CAT-Z embryos after injection
at E9.5, and no lacZ+ cells were observed (data not shown).
As an additional test of specificity of tamoxifen-dependent
Cre recombinase activity, we performed PCR for the recom-
bined reporter allele. PCR genotyping analyses showed that the
treated embryo had both the Olig2KICreER allele and the
Fig. 2. Temporal- and site-specific recombination in the central nervous system of the Olig2KICreER/WT CAT-Z double-heterozygote embryo. (A) Scheme of 4-OHT
administration protocol. (B–D)Whole-mount X-gal staining of E12.5Olig2KICreER/WT CAT-Z embryo treated with 4-OHTat E10.5.Olig2KICreER/WT CAT-Zmales were
crossed to wild-type females, and pregnant females were injected with 1.5 mg of 4-OHT intraperitoneally at E10.5. Then, Olig2KICreER/WT CAT-Z embryos were
examined for lacZ expression. LacZ expression was observed in the pMN domain and in the ventral horn. (E, F) Whole-mount X-gal staining of control E12.5
Olig2KICreER/WT CAT-Z embryo given sesame oil–DMSO–ethanol (“carrier alone”). LacZ expression was not observed in the central nervous system. (G) PCR
analyses of genomic DNAs from Olig2KICreER/WT CAT-Z embryos with or without administration of 4-OHT (lanes 1, 2, respectively) and negative control (lane 3).
Nuclease-free water was used as template in the negative control. Specific primer sets were used for the wild-type Olig2WT allele and Olig2KICreER allele (upper panel),
CAT-Z allele (middle panel), or recombined CAT-Z allele (lower panel). Olig2KICreER/WT CAT-Z embryos treated with 4-OHT exhibit a 247-bp wild-type Olig2 band,
367 bp mutant Olig2 band, and 580 bp recombined reporter band (lane 1), while untreated embryos exhibit wild-type and mutant Olig2 bands, but not a recombined
reporter band (lane 2).
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while control embryos had no recombined reporter allele (Fig.
2G, lane 2 in lower panel). These findings indicate that
tamoxifen-dependent recombination of the reporter allele in
Olig2+ cells occurred only in the presence of tamoxifen.
Olig2+ cells in the ventricular zone generate multiple cell types
in the spinal cord
We next examined which types of cells were derived from
Olig2+ cells in the E9.5 ventricular zone of Olig2KICreER/WT
CAT-Z double-heterozygote embryos. 4-OHT was injected at
E9.5, when motoneurons are generated in the restricted Olig2+
pMN domain (Fig. 1A), and the pattern of lacZ gene expression
was examined at E11.5, E14.5, and E18.5. To identify the cell
types of lacZ+ cells, X-gal-stained sections were co-stained with
cell type-specific markers. As expected, at E11.5, lacZ
expression was observed in ventral ventricular cells in the
pMN domain and in cells of the ventral horn (Figs. 3A, B).
LacZ+ cells in the ventral horn were identified as motoneurons
by Islet-1 (Isl1), a marker for motoneurons, at E11.5 (Fig. 3C)
and E14.5 (Fig. 3G), and NeuN, a marker for neurons, at laterstages (Fig. 3L). As these findings showed, only a fraction of
the motoneurons and cells in the pMN domain expressed lacZ,
indicating that not all the Olig2+ cells underwent recombination
as a result of 4-OHT injection. To estimate percentage
recombination efficiency, we counted lacZ+ cells by X-gal
staining and Olig2+ cells by ISH in the ventricular zone of the
thoracic spinal cord on serial sections of E11.5 Olig2KICreER/WT
CAT-Z embryos treated with 4-OHT at E9.5. The percentage of
LacZ+ cells among Olig2+ cells in the ventricular zone ranged
from 8.9% to 10.8% (as counted in at least nine sections at
thoracic level per embryo from 3 embryos).
At E14.5, lacZ expression was again observed in cells in the
pMN domain and in Isl1+ motoneurons in the ventral horn
(Figs. 3D–G). In addition, X-gal signal was found in scattered
cells in the parenchyma outside of the ventricular zone (Fig. 3E,
arrowhead). These scattered cells were identified as OLPs based
on morphological features including a small nucleus and scant
cytoplasm as well as co-staining with PDGFRα, a marker for
OLPs (data not shown).
At E18.5, lacZ+/NeuN+ motoneurons in the ventral horn (Fig.
3L) and scattered lacZ+/PDGFRα+ OLPs in the mantle layer
(Fig. 3M) were also observed. Interestingly, types of cells other
Fig. 3. Olig2+ cells in the ventricular zone generate multiple cell types in spinal cord. X-gal staining was performed on sections of spinal cord of E11.5 (A–C), E14.5
(D–G) and E18.5 (H–O) Olig2KICreER/WT/CAT-Z double-heterozygote embryos treated with 4-OHT at E9.5. X-gal-stained sections were counterstained using nuclear
fast red (A, B, D–F, H–K, P, Q) or immunostained using anti-Islet1 (Isl1) antibody (C, G), anti-NeuN antibody (L), anti-PDGFRα antibody (M), or anti-GFAP
antibody (N, O). B, E, F, and I–K show higher-magnification views of boxed areas in panels A, D, and H. (A, B) In E11.5 spinal cord, lacZ expression is present only in
the pMN domain and the ventral horn. (C) LacZ+ cells in the ventral horn were confirmed to be motoneurons by Isl1 immunostaining. The arrowhead indicates a lacZ+/
Isl1+ motoneuron. (D–G) In E14.5 spinal cord, lacZ expression is still present mainly in the pMN domain (D, E) and the ventral horn (D, F). LacZ+ cells were also
observed in the mantle layer (E, arrowhead), and were confirmed to be oligodendrocyte progenitors by PDGFRα immunostaining (data not shown). (G) LacZ+ cells in
the ventral horn were confirmed to be motoneurons by Isl1 immunostaining. The arrowhead indicates a lacZ+/Isl1+ motoneuron. (H–O) In E18.5 spinal cord, lacZ+
cells are widespread mainly in the ventral half of spinal cord, and their number is increased. LacZ+ cells were seen in the ventral horn (I, red arrowhead) and mantle
layer (I, black arrowhead). In addition, lacZ+ cells are present at the pial surface (H, J) and around the central canal (H, I, K). Note that lacZ+ cells were not seen in the
subpial zone at E11.5 (A) and E14.5 (D). (L–O) Arrowheads indicate cells doubly positive for X-gal staining and NeuN (L), PDGFRα (M), or GFAP (N, O)
immunostaining. (P) Representative images of E18.5 spinal cord of Olig2KICreER/WT CAT-Z treated with 4-OHT at E14.5. LacZ+ cells were detected in the parenchyma
(arrowheads) and at the ventral pial surface (arrows), but not in the ventral horn (dotted circles). (Q) In another section of the same animal as in (P), lacZ+ cells were
also observed in the ventricular zone. Scale bars: panels A, I, 100 μm; panels B, C, E, F, G, J, Q, 50 μm; panels H, P, 250 μm; panels K–O, 25 μm; panel D, 200 μm.
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example, many lacZ+ cells were observed at the ventral border of
the spinal cord (Figs. 3H–J). These cells were identified as
astrocytes based on their location in the glia limitans, co-staining
with GFAP, a marker for astrocytes (Fig. 3N), and electron
microscopic analysis (Fig. 4A). LacZ+ cell at the ventral border
of the spinal cord (Fig. 4A, inset) is directly in contact with the
basal lamina of the pia mater and has veil-like processes (Fig.4A, arrows), both of which are typical astrocytic ultrastructure
(Chan-Palay and Palay, 1972; Kosaka and Hama, 1986). Of
note, almost all lacZ- and GFAP-double-positive astrocytes were
observed in the ventral spinal cord (Fig. 3). Double positive
astrocytes are also detected in the mantle layer (Fig. 3O). These
GFAP+ astrocytes were Olig2-negative, as confirmed by double-
labeling with Olig2 ISH and GFAP immunostaining (data not
shown, see also Takebayashi et al., 2000). LacZ+ cells were also
Fig. 4. Olig2+ progenitors give rise to astrocyte and ependymal cell. Slices of
E18.5 Olig2KICreER/WT CAT-Z spinal cord treated with tamoxifen at E9.5 were
embedded in Epon after X-gal staining. After observation by light microscopy,
slices were treated for observation by transmission electron microscopy (TEM).
(A) An electron micrograph of a lacZ+ cell at the ventral border of the spinal
cord. A subpial lacZ+ cell (arrow in inset) is observed under an electron
microscope. White arrowheads indicate X-gal reaction product. The lacZ+ cell is
directly in contact with the basal lamina (BL) of the pia mater (black arrows) and
has veil-like processes (black arrowheads); both are a typical astrocytic
ultrastructure. The inset shows a semi-thin section of lacZ+ cells in the anterior
horn of the spinal cord. (B) An electron micrograph of a lacZ+ cell around the
central canal. The indicated lacZ+ cell faces the central canal (cc) directly. White
arrowheads indicate X-gal reaction product. The inset shows a higher-
magnification view of the boxed area. The basal body (inset, black arrow)
and adherens junction (inset, white arrow) were observed on the apical side; both
are morphological characteristics of mature ependymal cells. Abbreviations:
CC, central canal; Nc, nucleus; BL, basal lamina. Scale bars: panels A, B, 2 μm;
inset in panel A, 25 μm; insets in panel B, 500 nm.
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3I, K). Similar to the astrocytes in the glia limitans, these cells
did not express Olig2 (data not shown). These cells were
identified as ependymal cells based on electron microscopic
analysis (Fig. 4B). LacZ+ cells around the central canal directly
faced the lumen (Fig. 4B), had basal bodies (inset of Fig. 4B,
black arrow), which are structures found at the foot of cilia, and
formed adherens junctions between the adjacent ventricular cells
(inset of Fig. 4B, white arrow). These findings are consistent
with characteristic features of ependymal cells (Bruni and
Reddy, 1987; Seitz et al., 1981).To further confirm tamoxifen-dependent recombination, we
injected 4-OHT at E14.5, when motoneuron generation has
ceased and many oligodendrocyte are produced, and examined
embryos at E18.5 (Fig. 3P). At this stage, lacZ+ cells were
observed in the parenchyma, including the dorsal spinal cord
(Fig. 3P arrowheads), ventral surface of the spinal cord (Fig. 3P,
arrow), and in the ventricular zone around the central canal (Fig.
3Q), as observed with 4-OHT injection at E9.5. However, no
lacZ+ cells were observed in the ventral horn (Fig. 3P, dotted
circles) where motoneurons reside. Overall, the number of
lacZ+ cells was drastically decreased compared with adminis-
tration of 4-OHT at E9.5, probably due to a decrease of Olig2
expression during development and/or to longer proliferation
period in the younger 4-OHT injected embryos. The change in
pattern of expression of the reporter gene with injection of 4-
OHT further confirmed the specificity of the CreER/loxP
system.
Differentiation potency of Olig2+ cells at later embryonic
stages
To confirm the results obtained using Olig2KICreER/WT CAT-Z
mice, we used another reporter line, Z/EG mouse (Novak et al.,
2000), which expresses GFP, a suitable marker for double
immunohistochemistry and quantitative analyses, after tamox-
ifen-dependent recombination. We injected 4-OHT into
Olig2KICreER/WT Z/EG mice at E9.5 and performed examination
at E18.5. The pattern of distribution of GFP+ cells (Fig. 5A) was
comparable to that of lacZ+ cells in Olig2KICreER/WT CAT-Z
mice. To identify the cell types of these GFP+ cells, we
performed double-immunostaining with anti-GFP antibody and
cell type-specific markers, including NeuN for neurons,
PDGFRα, a marker for OLPs, and GFAP for astrocytes.
NeuN+ cells were counted as motoneurons based on their
location, their large nuclei, and positive reaction for neurofila-
ment marker 2H3 (data not shown). We observed GFP+/
PDGFRα+ OLPs in the mantle layer (Fig. 5B), GFP+/NeuN+
motoneurons in the ventral horn (Fig. 5C), and GFP+/GFAP+
astrocytes at the pial surface (Fig. 5D). These GFP+/GFAP+
cells were also confirmed to be astrocytes by double-labeling
with another astrocyte marker, anti-S100β antibody. We
detected GFP+/S100β+ cells at the pial surface (Fig. 5E) and
also in the mantle layer (Fig. 5F). These findings support the
hypothesis that Olig2+ progenitors in the pMN domain generate
astrocytes. GFP+ cells around the central canal were also
observed (Fig. 5G). Taken together, these findings clearly show
that Olig2+ progenitors produce not only motoneurons and
oligodendrocytes, but also a subset of astrocytes in the ventral
spinal cord and ependymal cells.
Next, to investigate the differentiation potency of Olig2+
cells at various embryonic stages, we injected 4-OHT at E9.5,
E12.5, and E14.5, and examined rates of generation of
motoneurons, OLPs, and astrocytes by double-immunostaining
with GFP and the cell type-specific markers NeuN, PDGFRα,
and GFAP, respectively. Motoneurons were not detected with
injection after E12.5 (Fig. 5H), consistent with the report that
the neuron/glia switch occurs by E12 (Richardson et al., 2000).
Fig. 5. Rates of generation of motoneurons, oligodendrocyte progenitors, and astrocytes depend on the stage of tamoxifen treatment. (A) Representative image of
spinal cord from E18.5Olig2KICreER/WT Z/EG embryos treated with 4-OHTat E9.5. GFP+ cells are also observed in the parenchyma (arrowheads) and at the ventral pial
surface (arrows), and around the central canal (G), as in the case ofOlig2KICreER/WT CAT-Z. (B–F) Representative confocal images of double-immunostaining with anti-
GFP antibody and anti-PDGFRα antibody (B), anti-NeuN antibody (C), anti-GFAP antibody (D), or anti-S100β antibody (E, F). (H–J) Percentages of GFP+ cells that
co-express NeuN (H), PDGFRα (I), or GFAP (J) in Olig2KICreER/WT Z/EG thoracic spinal cord at E18.5, following administration of 4-OHT at E9.5, E12.5, or E14.5.
Numbers are percentages ± SD of doubly positive cells among all GFP+ cells from at least twenty-six sections per embryo from three embryos, respectively. The total
numbers of GFP+ cells counted on sections of mice treated at E9.5 (n = 3), E12.5 (n = 3), and 14.5 (n = 3) were 1530, 533, and 756, respectively. The mean
numbers ± SD of GFP+ cells per section (18 μm-thickness) of mice treated at E9.5, E12.5, and 14.5 were 9.9 ± 0.6, 3.7 ± 0.1, and 3.4 ± 0.5, respectively. GFP+/NeuN+
double-positive cells are not detected with injection at E12.5 or E14.5. Percentage of PDGFRα+/GFP+ cells is increased with later injection. Scale bars: panel A,
100 μm; panels B–F, 20 μm; panel G, 50 μm.
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366 N. Masahira et al. / Developmental Biology 293 (2006) 358–369In contrast to motoneuron labeling, OLP labeling increased with
later injection (Fig. 5I). The rate of OLP labeling was greater at
E14.5 than at E12.5. This increase may be due to extensive
proliferation of migrating OLPs, as well as genesis of
oligodendrocytes from dorsal domains (see Discussion).
Generation of astrocytes was constantly observed, at a rate
that did not differ significantly by stage of injection (Fig. 5J).
Olig2+ radial glial cells in the pMN domain
Previous studies showed that radial glial cells give rise to all
major types of cells in developing CNS, that is, neuronsFig. 6. Olig2+ radial glial cells in the pMN domain. (A, B) Olig2+ cells in the ventricul
Olig2 probe on a section of E11.5 wild-type embryo. RC2+ radial fibers extend from
An Olig2+ cell at the ventricular zone of the pMN domain (arrow) has RC2+ radial fib
of E11.5 (C) and E12.5 (D) wild-type spinal cord using combinations of the followin
and D indicates cell doubly positive for Olig2 and RC2, or Olig2 and GLAST, resp
immunostaining for Olig2 (E, G) and RC2 (F, G) in cells acutely dissociated from E11
Nuclei are stained with Hoechst 33342. (I–L) Heterogeneity of Olig2+ cells in the pMN
section of E10.5 wild-type spinal cord using combinations of the following antibodies
antibody, (L) anti-Olig2 antibody and probe for Ngn2. (I) Olig2+ cells in the lateral b
Olig2+ cells are already committed to motoneuronal fate and that Olig2+ cells exhib
[mean ± SD], Olig2+HB9+/Olig2+, six pMN domains from 3 embryos). Asterisks
ventricular zone of the pMN domain. (K) A higher magnification view of the boxed ar
Olig2 after ISH for Ngn2. Black arrowhead indicates Olig2+/Ngn2+ cell in the ventric
Asterisks represent the central canal. Scale bars: panels A, I, J, 50 μm; panels B, D(Alvarez-Buylla et al., 1990;Malatesta et al., 2000;Miyata et al.,
2001; Noctor et al., 2001; Tamamaki et al., 2001), OLPs (Choi
andKim, 1984; Fogarty et al., 2005; Hirano andGoldman, 1988;
Ono et al., 2001), astrocytes (Bignami and Dahl, 1974; Levitt
and Rakic, 1980; Parnavelas and Nadarajah, 2001), and
ependymal cells (Spassky et al., 2005). Since all of these cell
types are produced from the Olig2+ pMN domain, we examined
whetherOlig2+ cells in this domain have characteristics of radial
glial cells, using the radial glial marker RC2. With double-
labeling using Olig2-mRNA probes and RC2 antibody (Figs.
6A, B) and anti-Olig2 antibody and RC2 antibody (Fig. 6C,
arrowhead) in E11.5 spinal cord, we detected Olig2+ cellsar zone possess radial fibers. (A) Immunostaining for RC2 antibody after ISH for
the pMN domain. (B) A higher-magnification view of the boxed area in panel A.
ers (arrowheads). (C, D) Confocal images of double-immunostaining on sections
g antibodies: (C) Olig2 and RC2, (D) Olig2 and GLAST. Arrowhead in panels C
ectively. Asterisks in panels C and D represent the central canal. (E–H) Double
.5 spinal cord. (G) Olig2- and RC2- double positive cell is observed (arrow). (H)
domain. Double-immunostaining (I–K) and immunostaining after ISH (L) on a
and probes: (I) antibodies for HB9 and Olig2, (J, K) RC2 antibody and anti-HB9
order of the ventricular zone are double-positive for HB9, indicating that some
it heterogeneity. The brackets show area of Olig2+/HB9+ cells (17.1% ± 3.9%
represent the central canal. (J) HB9+/RC2+ radial glial cell (arrowhead) in the
ea in panel J. Arrowhead indicates HB9+ radial glial cell. (L) Immunostaining for
ular zone of the pMN domain, and white arrowhead indicates Olig2+/Ngn2− cell.
, 20 μm; panels C, E–H, K, L, 25 μm.
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glial cells are also confirmed by RC2 and Olig2 double
immunocytochemistry in dissociation culture of E11 spinal
cord (Figs. 6E–H). In addition, Olig2+ cells in the pMN domain
possessed GLAST+ fibers at E12.5 (Fig. 6D, arrowhead). Since
GLAST appears to be expressed in glial progenitors (Shibata et
al., 1997) and motoneuron production has ceased by this stage
(Richardson et al., 2000), these findings suggest that some
Olig2+ cells in the pMN domain have characteristics of radial
glial cells during neurogenesis and gliogenesis.
Next, we tested the hypothesis that Olig2+ progenitors
exhibit heterogeneity in the early pMN domain. We performed
double-labeling using anti-Olig2 antibody and anti-HB9
antibody, a marker for the earliest post-mitotic motoneurons
(Arber et al., 1999). Olig2+ cells in the lateral border of the
pMN domain co-expressed HB9, demonstrating heterogeneity
of Olig2+ cells in the pMN domain (Fig. 6I, brackets) in
accordance with differentiation stage. We detected a small
number of HB9+ radial glial cells in the ventricular zone of
E10.5 spinal cord (Figs. 6J, K, arrowhead) (2.5 ± 2.4%
[mean ± SD] of all HB9+ cells; counted in six pMN domains
from 3 embryos), demonstrating heterogeneity of Olig2+ radial
glial cells. Finally, we used Ngn2 as a marker for motoneuron
progenitors, since co-expression of Olig2 and Ngn2 appears to
be a hallmark of motoneuron commitment (Mizuguchi et al.,
2001; Novitch et al., 2001). Approximately one third of Olig2+
progenitors in the pMN domain were Ngn2-positive (Fig. 6L,
also see (Mizuguchi et al., 2001; Novitch et al., 2001). The
percentage of Olig2+/Ngn2− cells among all Olig2+ cells in the
pMN domain ranged from to 54.1% to 71.3% (as counted in
three sections per embryo from 5 embryos). A small number of
Ngn2+ radial glia were also detected by double-staining with
probe for Ngn2 and RC2 antibody (data not shown). These
findings demonstrate that Olig2+ progenitors, including Olig2+
radial glial cells, exhibit heterogeneity in the pMN domain at
neurogenic stage.
Discussion
We examined the fate of Olig2+ cells during embryonic
spinal cord development using the tamoxifen-inducible CreER/
loxP system. In this system, Olig2+ cells in the pMN domain
can be genetically labeled within a specific developmental time
window and their progeny followed to later embryonic stages.
We definitively demonstrated that motoneurons and OLPs
originated from Olig2+ cells in the pMN domain. In addition,
we found that Olig2+ cells in the pMN domain produce a subset
of astrocytes at the ventral spinal cord including cells that form
the glia limitans and ependymal cells at the ventricular zone.
Comparison with previous lineage tracing studies using
Olig1-Cre and Olig2-GFP mice
Previous lineage-tracing studies using Olig1-Cre and Olig2-
GFP mice reported that only motoneurons and oligodendro-
cytes, but not astrocytes, are produced from the pMN domain
(Lu et al., 2002; Zhou and Anderson, 2002). In contrast, ourlineage-tracing experiments using Olig2KICreER mice showed
that Olig2+ cells in the pMN domain do produce a subset of
astrocytes, in addition to motoneurons and OLPs. This
discrepancy in findings may exist for the following important
reasons. First, lineage tracing experiments using Olig2-GFP
mice (Zhou and Anderson, 2002) are dependent on transient
GFP expression, and are therefore insensitive in detecting
progeny that down-regulate Olig2. Since Olig2 inhibits
astroglial differentiation and Olig2 is down-regulated during
astrocyte development (Fukuda et al., 2004; Gabay et al., 2003),
astrocytes of Olig2+ progeny cannot be detected in Olig2-GFP
mice. Although subsequent lineage tracing experiments using
Olig1-Cre mice permitted tracing of progeny of Olig1+ cells
using β-gal activity, only the optic nerve and forebrain were
examined (Lu et al., 2002). Since labeled astrocytes were
observed only in ventral spinal cord in our lineage tracing
experiments, there may also be biased localization of labeled
astrocytes in the forebrain of Olig1-Cre ROSA26R mice,
making them difficult to detect. Another possible reason for
the discrepancy in findings noted above is that ROSA26R
reporter mice fail to express reporter genes in astrocytes, as
reported in the forebrain (Malatesta et al., 2003).
In a more recent lineage-tracing study, Liu and Rao
determined the fate of Olig1+ progenitors in the spinal cord
using the same Olig1-Cre ROSA26R mice, and observed
GFAP+/lacZ+ astrocytes at the ventral glia limitans of P1 spinal
cord (Liu and Rao, 2004). Although we reached similar
conclusion, it is difficult to determine whether the Cre-
recombined lacZ+ astrocytes they observed were derived from
a restricted Olig1/2+ pMN domain. Because Cre recombinase is
active in all Olig1+ cells including migrating OLPs in
parenchyma, not only those derived from pMN domain, but
also those derived from dorsal domains at later stages (Cai et al.,
2005; Fogarty et al., 2005; Vallstedt et al., 2005). Since we
injected 4-OHT at E9.5, which has a relatively short half-life
(6 h) (Robinson et al., 1991), and Olig2 expression is clearly
restricted to the pMN domain until E11.5, our Olig2KICreER
mice enabled temporally-specific lineage tracing experiments
and provide stronger evidence for generation of astrocyte from
Olig2+ cells in the pMN domain.
Ependymal cell generation from Olig2+ cells
In this study, we also detected lacZ+ or EGFP+ ependymal
cells in both types of double-transgenic mice, consistent with
previous reports (Fu et al., 2003; Leber et al., 1990). Leber et
al. performed retroviral lineage tracing in chick embryonic
spinal cord and demonstrated that motoneurons and at least
some ependymal cells originate from a common precursor. Fu
et al. showed that spinal cord ependymal cells are derived
from Nkx6.1+ ventral neuroepithelial cells, which include
Olig2+ cells in the pMN domain (Fu et al., 2003). The
frequency of appearance of labeled ventricular cells was very
low, less than 1–3% among labeled cells through all stages of
injection. Although very rarely, we observed labeled ventric-
ular cells with tamoxifen injection as late as E15.5 (data not
shown).
368 N. Masahira et al. / Developmental Biology 293 (2006) 358–369Are there multipotential Olig2+ cells in the embryonic spinal
cord?
We observed that Olig2+ cells in the pMN domain possess
radial fibers at both neurogenic and gliogenic stages (Figs. 5A–
D). As noted above, many lines of evidence indicate that radial
cells give rise to all major cell types in the developing CNS.
Although we have shown that the Olig2+ pMN domain gives
rise to all major cell types in CNS, further investigation is
needed to determine whether Olig2+ radial glial cells also give
rise to motoneurons, OLPs, astrocytes, and/or ependymal cells
in the pMN domain. We think there is a possibility that Olig2+
cells in the ventricular zone of the pMN domain generate
motoneurons first, then OLPs, and finally astrocytes or
ependymal cells. That is, some Olig2+ cells in the pMN domain
may generate all types of CNS cells and therefore be
multipotent, as in the “switching model” (Richardson et al.,
2000; Rowitch et al., 2002). However, this does not exclude the
possibility that Olig2+ cells are heterogeneous and that more
fate-restricted Olig2+ progenitors are included in the pMN
domain (Richardson et al., 2000; Rowitch et al., 2002). Indeed,
we observed heterogeneity in Olig2+ progenitors in terms of
HB9 and Ngn2 expression, even among Olig2+ radial glial cells
(Figs. 5E–H), indicating that Olig2+ cells in the pMN domain
are in various differentiation stages. Heterogeneity among
progenitors in the pMN domain was recently suggested by
another study, in which the authors propose that MNs and OLPs
do not share a common-lineage restricted progenitor in vivo
(Wu et al., 2006). In this study, normal numbers of Olig2+ OLPs
were observed in the pMN domain of Olig1-Cre/Rosa26-
floxed-DTA mice, in which all MN precursors have been killed.
While this result may seem in conflict with our results, we may
be able to reconcile the two findings by tracing the lineage of
MN precursors and OLPs to the neural stem cell (NSC) level. In
their proposed model (Fig. 1C in Wu et al. 2006), the progenies
of the earliest pMN NSCs include both MN and glial cells.
Therefore it remains possible that multipotential Olig2+ cells
exist in the pMN domain. To demonstrate the existence of
multipotential cells in vivo, it will be necessary to conduct
lineage tracing studies at the single-cell level with good
temporal resolution.
In addition to examining the fate of Olig2+ cells in the
embryonic spinal cord, we have established a method for
temporally-specific recombination in the Olig2 lineage using
the CreER/loxP system. Our system will aid elucidation of the
molecular mechanisms of cell specification in this lineage.
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